Product Information

CETIRIZINE HCL 5 MG CHEW TAB is a generic product labeled by Sandoz Inc., priced at $1.9368 per EA under NDC 00781528364. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Feb 14, 2008.

The High Outlier badge above means this manufacturer's average price in the Cetirizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CETIRIZINE HCL 5 MG CHEW TAB

Cetirizine Hydrochloride
$1.9368per EA
High Outlier
OTC

Strength

5 mg/1

Manufacturer

Sandoz Inc.

NDC

00781528364

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CETIRIZINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078692

FDA Approved

2/14/2008

On Market Since

2/14/2008

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for CETIRIZINE HCL 5 MG CHEW TAB has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 13.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9368 per EA
All-time high$4.1494 (Jul 12, 2017)
All-time low$1.4032 (Feb 17, 2021)
52-week high$2.1468
52-week low$1.9368
Median price$2.0001
Average price$2.1113
Largest weekly change+128.2% (Jul 22, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-1.8%

1M

-2.8%

3M

-2.7%

6M

-4.7%

1Y

-9.0%

3Y

-7.1%

5Y

+13.1%

All

+13.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CETIRIZINE HCL 5 MG CHEW TAB?

The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG CHEW TAB, manufactured by Sandoz Inc., is $1.9368 per EA (NDC 00781528364), effective Nov 18, 2026.

How has the price of CETIRIZINE HCL 5 MG CHEW TAB changed over time?

Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG CHEW TAB has risen 13.8%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG CHEW TAB?

Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG CHEW TAB has ranged from a low of $1.4032 (Feb 17, 2021) to a high of $4.1494 (Jul 12, 2017), with a median of $2.0001 per EA.

Are there cheaper alternatives to CETIRIZINE HCL 5 MG CHEW TAB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CETIRIZINE HCL 5 MG TABLET, is $0.0446 per EA — about 98% below CETIRIZINE HCL 5 MG CHEW TAB.

Who manufactures CETIRIZINE HCL 5 MG CHEW TAB?

CETIRIZINE HCL 5 MG CHEW TAB (NDC 00781528364) is labeled by Sandoz Inc., and CMS classifies it as a generic product.